Otonomy Receives FDA Clearance To Initiate Clinical Trial In Patients With Meniere’s Disease
Otonomy, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted clearance of the company’s Investigational New Drug (IND) application for the clinical trial of OTO-104 in patients with Meniere’s disease, a debilitating disorder of the inner ear affecting balance and hearing…